Speaker illustration

Doctor Peter Vibe Rasmussen

Gentofte University Hospital, Copenhagen (Denmark)

Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study

Event: EHRA 2022

Topic: Oral Anticoagulation

Session: What is new on stroke prevention

Thumbnail

Anti-arrhythmic drugs confer increased risks of bradyarrhythmia in patients undergoing direct current cardioversion for atrial fibrillation.

Event: ESC Congress 2020

Topic: Rhythm Control, Cardioversion

Session: Atrial Fibrillation ePosters

Thumbnail

Older patients with atrial fibrillation and comorbidities are less likely to be treated with oral anticoagulation: insights from a nationwide study

Event: ESC Congress 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 4

Thumbnail

Gastrointestinal bleeding is associated with gastrointestinal cancer in patients with atrial fibrillation treated with anticoagulants - A nationwide study

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb